Compare NBIX & BSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NBIX | BSY |
|---|---|---|
| Founded | 1992 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.2B | 10.1B |
| IPO Year | 1996 | 2002 |
| Metric | NBIX | BSY |
|---|---|---|
| Price | $131.88 | $35.12 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 22 | 12 |
| Target Price | ★ $180.82 | $49.08 |
| AVG Volume (30 Days) | 1.0M | ★ 2.4M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 0.80% |
| EPS Growth | ★ 41.95 | 18.06 |
| EPS | ★ 4.67 | 0.85 |
| Revenue | $161,626,000.00 | ★ $734,849,000.00 |
| Revenue This Year | $24.73 | $14.13 |
| Revenue Next Year | $13.14 | $10.44 |
| P/E Ratio | ★ $28.58 | $41.28 |
| Revenue Growth | ★ 977.51 | 6.24 |
| 52 Week Low | $100.83 | $30.83 |
| 52 Week High | $160.18 | $59.25 |
| Indicator | NBIX | BSY |
|---|---|---|
| Relative Strength Index (RSI) | 51.80 | 50.31 |
| Support Level | $124.29 | $31.27 |
| Resistance Level | $136.23 | $35.46 |
| Average True Range (ATR) | 4.36 | 1.26 |
| MACD | 0.20 | 0.15 |
| Stochastic Oscillator | 72.29 | 86.30 |
Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.
Bentley Systems is a software vendor that caters to civil engineers, constructors, and geospatial professionals by enabling design, simulation, and data management of infrastructure assets such as roads and bridges. While Bentley is smaller than many other design software companies, it is a market leader across a handful of specialty areas, including public works, electricity grids, and transit.